Roche and Technoclone have announced that they have entered a strategic alliance to co-develop a portfolio of coagulation assays. Technoclone is a reagent specialist in thrombosis and cardiovascular diagnostics. Under the deal, Roche will also market Technoclone’s range of Research Use Only products that address the needs of specialists and researchers in the hemostasis research community. Further terms of the alliance were not announced.
Advertisement
